Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome) Overview
Learn About Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)
View Main Condition: Mucopolysaccharidoses (MPS)
Mucopolysaccharidosis type II (MPS II), also known as Hunter syndrome, is a condition that affects many different parts of the body. The condition occurs almost exclusively in boys, although it has been reported in a few girls. It is a progressively debilitating disorder; however, the rate of progression varies among affected individuals.
Variants (also called mutations) in the IDS gene cause MPS II. The IDS gene provides instructions for producing the I2S enzyme, which is involved in the breakdown of large sugar molecules called glycosaminoglycans (GAGs). GAGs were originally called mucopolysaccharides, which is where this condition gets its name.
MPS II occurs in approximately 1 in 100,000 to 1 in 170,000 males.
This condition is inherited in an X-linked recessive pattern. The gene associated with this condition is located on the X chromosome, which is one of the two sex chromosomes. In males (who have only one X chromosome), one altered copy of the gene in each cell is sufficient to cause the condition. In females (who have two X chromosomes), a variant would have to occur in both copies of the gene to cause the disorder. Because it is unlikely that both copies of a gene would be altered, males are affected by X-linked recessive disorders much more frequently than females. A characteristic of X-linked inheritance is that fathers cannot pass X-linked traits to their sons.
Kristin Lindstrom is a Medical Genetics specialist and a Pediatrics provider in Phoenix, Arizona. Dr. Lindstrom and is rated as an Experienced provider by MediFind in the treatment of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). Her top areas of expertise are 1p36 Deletion Syndrome, Phenylketonuria (PKU), Floating-Harbor Syndrome, and Kozlowski Warren Fisher Syndrome.
Daniel Julien is a Hospital Medicine specialist and a Pediatric Hematologist Oncology provider in Phoenix, Arizona. Dr. Julien and is rated as an Experienced provider by MediFind in the treatment of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). His top areas of expertise are Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), Hemoglobin C Disease, Hemoglobinopathy, and Hemoglobin E Disease. Dr. Julien is currently accepting new patients.
Holly Miller is a Pediatric Hematologist Oncology specialist and a Pediatrics provider in Phoenix, Arizona. Dr. Miller and is rated as an Experienced provider by MediFind in the treatment of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). Her top areas of expertise are Severe Combined Immunodeficiency (SCID), Infantile Neutropenia, Wiskott-Aldrich Syndrome, Vitamin D Deficiency, and Bone Marrow Transplant. Dr. Miller is currently accepting new patients.
Summary: Newborn screening (NBS) is a global initiative of systematic testing at birth to identify babies with pre-defined severe but treatable conditions. With a simple blood test, rare genetic conditions can be easily detected, and the early start of transformative treatment will help avoid severe disabilities and increase the quality of life. Baby Detect Project is an innovative NBS program using a pane...
Summary: The goal of this observational study is to characterize the epidemiology and natural history of MPS diseases by building a retrospective and prospective collection of extensive phenotypic data from French MPS patients.
Published Date: October 05, 2023
Published By: National Institutes of Health